CN102048933B - 一种治疗小儿腹泻的中药组合物及其制备方法 - Google Patents
一种治疗小儿腹泻的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN102048933B CN102048933B CN2010105952883A CN201010595288A CN102048933B CN 102048933 B CN102048933 B CN 102048933B CN 2010105952883 A CN2010105952883 A CN 2010105952883A CN 201010595288 A CN201010595288 A CN 201010595288A CN 102048933 B CN102048933 B CN 102048933B
- Authority
- CN
- China
- Prior art keywords
- parts
- spleen
- diarrhea
- medicine
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 208000019637 Infantile Diarrhea Diseases 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 157
- 244000268590 Euryale ferox Species 0.000 claims abstract description 13
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 13
- 235000006784 Saussurea lappa Nutrition 0.000 claims abstract description 13
- 241000628997 Flos Species 0.000 claims abstract description 7
- 239000000454 talc Substances 0.000 claims abstract description 7
- 229910052623 talc Inorganic materials 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims description 37
- 210000000582 semen Anatomy 0.000 claims description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 17
- 238000010438 heat treatment Methods 0.000 claims description 16
- 239000010271 massa medicata fermentata Substances 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 210000003038 endothelium Anatomy 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 6
- 235000012222 talc Nutrition 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 206010013786 Dry skin Diseases 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 241000555682 Forsythia x intermedia Species 0.000 claims description 2
- 241000498779 Myristica Species 0.000 claims description 2
- 241000219295 Portulaca Species 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 241000206469 Pulsatilla Species 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims 1
- 241001664510 Saussurea costus Species 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 abstract description 109
- 210000000952 spleen Anatomy 0.000 abstract description 82
- 210000002784 stomach Anatomy 0.000 abstract description 57
- 230000000694 effects Effects 0.000 abstract description 56
- 210000003734 kidney Anatomy 0.000 abstract description 33
- 208000002193 Pain Diseases 0.000 abstract description 31
- 210000004072 lung Anatomy 0.000 abstract description 27
- 230000001105 regulatory effect Effects 0.000 abstract description 16
- 230000036528 appetite Effects 0.000 abstract description 13
- 235000019789 appetite Nutrition 0.000 abstract description 13
- 244000272264 Saussurea lappa Species 0.000 abstract description 12
- 231100000331 toxic Toxicity 0.000 abstract description 9
- 230000002588 toxic effect Effects 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 8
- 235000013399 edible fruits Nutrition 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 241000132012 Atractylodes Species 0.000 abstract 2
- 240000004510 Agastache rugosa Species 0.000 abstract 1
- 241000234282 Allium Species 0.000 abstract 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 abstract 1
- 241000304531 Allium macrostemon Species 0.000 abstract 1
- 208000035943 Aphagia Diseases 0.000 abstract 1
- 244000080767 Areca catechu Species 0.000 abstract 1
- 235000017965 Asarum canadense Nutrition 0.000 abstract 1
- 241000283690 Bos taurus Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 235000000385 Costus speciosus Nutrition 0.000 abstract 1
- 241000099774 Cuscuta salina Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 244000270834 Myristica fragrans Species 0.000 abstract 1
- 235000009421 Myristica fragrans Nutrition 0.000 abstract 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000294611 Punica granatum Species 0.000 abstract 1
- 235000014360 Punica granatum Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 208000031975 Yang Deficiency Diseases 0.000 abstract 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000001702 nutmeg Substances 0.000 abstract 1
- 230000003393 splenic effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 49
- 201000010099 disease Diseases 0.000 description 43
- 208000001848 dysentery Diseases 0.000 description 31
- 230000001717 pathogenic effect Effects 0.000 description 30
- 235000013305 food Nutrition 0.000 description 27
- 230000001737 promoting effect Effects 0.000 description 24
- 230000007812 deficiency Effects 0.000 description 23
- 206010047700 Vomiting Diseases 0.000 description 22
- 230000008673 vomiting Effects 0.000 description 21
- 235000005911 diet Nutrition 0.000 description 19
- 230000000968 intestinal effect Effects 0.000 description 19
- 238000012360 testing method Methods 0.000 description 19
- 230000001142 anti-diarrhea Effects 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 244000052769 pathogen Species 0.000 description 17
- 230000029087 digestion Effects 0.000 description 16
- 210000001113 umbilicus Anatomy 0.000 description 16
- 206010011224 Cough Diseases 0.000 description 14
- 230000037213 diet Effects 0.000 description 14
- 239000007789 gas Substances 0.000 description 14
- 235000019640 taste Nutrition 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 210000001015 abdomen Anatomy 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 13
- 210000002429 large intestine Anatomy 0.000 description 12
- 239000009806 pulsatillae Substances 0.000 description 12
- 208000000059 Dyspnea Diseases 0.000 description 11
- 206010013975 Dyspnoeas Diseases 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 11
- 206010030113 Oedema Diseases 0.000 description 11
- 208000004880 Polyuria Diseases 0.000 description 11
- 206010042674 Swelling Diseases 0.000 description 11
- 230000035619 diuresis Effects 0.000 description 11
- 230000014759 maintenance of location Effects 0.000 description 11
- 238000005728 strengthening Methods 0.000 description 11
- 230000008961 swelling Effects 0.000 description 11
- 230000035922 thirst Effects 0.000 description 11
- 208000019902 chronic diarrheal disease Diseases 0.000 description 10
- 201000006549 dyspepsia Diseases 0.000 description 10
- 230000003203 everyday effect Effects 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 230000001047 pyretic effect Effects 0.000 description 10
- 230000003014 reinforcing effect Effects 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 230000002159 abnormal effect Effects 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 9
- 239000010839 body fluid Substances 0.000 description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 210000002700 urine Anatomy 0.000 description 9
- 238000010792 warming Methods 0.000 description 9
- 206010000087 Abdominal pain upper Diseases 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 8
- 208000019790 abdominal distention Diseases 0.000 description 8
- 210000000481 breast Anatomy 0.000 description 8
- 230000004087 circulation Effects 0.000 description 8
- 230000001276 controlling effect Effects 0.000 description 8
- 206010061428 decreased appetite Diseases 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 210000001835 viscera Anatomy 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 206010037660 Pyrexia Diseases 0.000 description 7
- 230000002411 adverse Effects 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 7
- 210000003608 fece Anatomy 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 206010021118 Hypotonia Diseases 0.000 description 6
- 206010061245 Internal injury Diseases 0.000 description 6
- 230000003187 abdominal effect Effects 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 208000017561 flaccidity Diseases 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 235000011837 pasties Nutrition 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 230000035943 smell Effects 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 241000792859 Enema Species 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000378 dietary effect Effects 0.000 description 5
- 239000007920 enema Substances 0.000 description 5
- 229940095399 enema Drugs 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 230000003419 expectorant effect Effects 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 210000002683 foot Anatomy 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 210000001624 hip Anatomy 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 230000009545 invasion Effects 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 4
- 206010008631 Cholera Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 201000000297 Erysipelas Diseases 0.000 description 4
- 206010060891 General symptom Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010030302 Oliguria Diseases 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 241000702670 Rotavirus Species 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 4
- 208000022531 anorexia Diseases 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 208000002894 beriberi Diseases 0.000 description 4
- 208000013116 chronic cough Diseases 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 208000004371 toothache Diseases 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010024642 Listless Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 206010059013 Nocturnal emission Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000001166 anti-perspirative effect Effects 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 238000011443 conventional therapy Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000013872 defecation Effects 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000010135 fructus aurantii immaturus Substances 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000001889 Acid-Base Imbalance Diseases 0.000 description 2
- 208000008710 Amebic Dysentery Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010001986 Amoebic dysentery Diseases 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 206010004016 Bacterial diarrhoea Diseases 0.000 description 2
- 206010048909 Boredom Diseases 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- MKMCJLMBVKHUMS-UHFFFAOYSA-N Coixol Chemical compound COC1=CC=C2NC(=O)OC2=C1 MKMCJLMBVKHUMS-UHFFFAOYSA-N 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 206010011469 Crying Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012742 Diarrhoea infectious Diseases 0.000 description 2
- 208000036649 Dysbacteriosis Diseases 0.000 description 2
- 208000027244 Dysbiosis Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010014418 Electrolyte imbalance Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- 206010019705 Hepatic pain Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010057071 Rectal tenesmus Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 2
- 241000607762 Shigella flexneri Species 0.000 description 2
- 241000607760 Shigella sonnei Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 206010048222 Xerosis Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000507 anthelmentic effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000571 coke Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical group O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 230000007140 dysbiosis Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 150000002630 limonoids Chemical class 0.000 description 2
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical group C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 208000012271 tenesmus Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- GXFZCDMWGMFGFL-KKXMJGKMSA-N (+)-Tubocurarine chloride hydrochloride Chemical compound [Cl-].[Cl-].C([C@H]1[N+](C)(C)CCC=2C=C(C(=C(OC3=CC=C(C=C3)C[C@H]3C=4C=C(C(=CC=4CC[NH+]3C)OC)O3)C=21)O)OC)C1=CC=C(O)C3=C1 GXFZCDMWGMFGFL-KKXMJGKMSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001111317 Chondrodendron tomentosum Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 239000008589 Cortex Fraxini Substances 0.000 description 1
- 239000008709 Curare Substances 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000052343 Dares Species 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 208000008017 Hypohidrosis Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- OSKIPPQETUTOMW-YHLOVPAPSA-N N-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-5-[(2R,3S,4S,5R,6R)-4-[(2R,3S,4S,5S,6R)-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5R,6R)-6-[[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 OSKIPPQETUTOMW-YHLOVPAPSA-N 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 241000702263 Reovirus sp. Species 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010067470 Rotavirus infection Diseases 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010051511 Viral diarrhoea Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 201000009840 acute diarrhea Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 206010002512 anhidrosis Diseases 0.000 description 1
- 230000037001 anhydrosis Effects 0.000 description 1
- 230000003097 anti-respiratory effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 229940098166 bactrim Drugs 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000021551 crystal sugar Nutrition 0.000 description 1
- 239000008912 dachengqi decoction Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000000741 diarrhetic effect Effects 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- -1 filters Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 206010020488 hydrocele Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 229940095970 imodium Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000021125 infant nutrition Nutrition 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 238000002671 oral rehydration therapy Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000005090 tracheal smooth muscle Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000011844 whole wheat flour Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗小儿腹泻的中药组合物,所述组合物中内服药物中各种原料药为:白头翁,山药,炒芡实,石榴皮,云木香,肉豆蔻,白术,茯苓,葛根,薤白,大腹皮,黄连,陈皮。症见湿热泻加滑石,苍术,厚朴,薏仁。症见风寒泻加藿香,马齿苋,连翘,防风。症见纳差不食、脾肾阳虚泻加焦三仙,鸡内金,五味子,丁香。外用药物为:小茴香,肉桂,葱白,生麦芽,大青叶,细辛,黄柏,蒲公英。本发明的中药组合物具有止痛、理气健脾、补脾肺肾、补中益气和升阳止泻的功效,主治脾胃不调,和脾胃虚弱引起的腹泻;且制作工艺简便,毒副作用小且给药方便,药剂易于制造,成本低廉的新药。能直达病灶,治愈时间短,治愈后不复发。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物原料的医用配制品及其制备方法,特别涉及一种治疗小儿腹泻的中药组合物及其制备方法。
背景技术
小儿腹泻病是一组由多种病原,多种因素引起的,以腹泻为主要症状的儿科常见肠道疾病,是威胁儿童健康的主要疾病之一。轮状病毒(RV)是婴幼儿腹泻的最主要病原。根据世界卫生组织统计,全世界每年有1.3亿婴幼儿患轮状病毒腹泻,可造成87.3万人死亡。不论发达国家还是发展中国家,轮状病毒的感染率和发病率都很高。WHO认为90%的急性腹泻儿童可应用口服补液疗法,抗生素仅仅用于细菌性痢疾和“疑似霍乱”者,除此之外应用抗生素都没有价值。目前对轮状病毒腹泻国内外尚无特效治疗方法。临床治疗靠补液,纠正电解质紊乱及酸碱平衡失调等对症支持为主,疗效常不理想,且存在滥用抗生素,滥用静脉补液等问题。小儿患病后病情危重,静脉给药有一定困难,口服给药患儿常不合作,而且疗效欠佳。给治疗上带来很多困难,使病情迁延,同时也给家长及患儿在精神上,肉体上、经济上都带来了沉重的负担。为了减少滥用抗生素的危害,寻求一种既给药方便又有显著疗效的安全给药途.
小儿腹泻是儿科常见病、多发病,也是小儿最主要的死亡原因之一。在我国治疗腹泻时滥用抗生素现象十分严重,后果是造成细菌耐药性增强,肠道正常菌群紊乱,破坏了生理平衡,使腹泻迁延或加重。西药只能对症治疗,疗效欠佳。本病一年四季均可发生,尤以夏秋季最为多见且引起流行。目前临床上治疗此类疾病的药物多为口服制剂,且疗效不甚满意。由于婴幼儿脏腑娇嫩,胃肠功能发育不成熟,消化系统功能不健全,胃液中胃酸少,消化酶的活性差,而婴幼儿处于快速生长发育期,需要的营养多,相对胃肠道的负担较重,加之小儿寒暖不能自调,饮食不能自节,因此,外易受邪气侵袭,内易为饮食所伤。
泄泻乃小儿最常见的疾病,位于我国小儿常见病多发病的第二位,是导致婴幼儿死亡的主要原因之一,两岁以下的婴幼儿多见,四季均可发生。以小儿排便次数增多,大便性质改变(不消化的稀便、水样便、黏液便或脓血便)为主要表现。此外,还可伴有食欲低下,常有呕吐,严重者可吐出咖啡样液体,腹泻频繁,每日大便十几次到几十次,粪便呈水样或蛋花汤样,向外溅射,外观为黄绿色、黄色或微黄色,水量多而粪质少。全身一般情况较差,发热,体温可增至39℃~40℃,少数可高达41℃以上,小儿表现为烦躁不安、精神萎靡、意识朦胧,甚至昏迷,随着全身症状加剧,可引起神经系统、心、肝、肾等功能失调。腹泻轻者影响小儿营养吸收,重者多因伴有脱水、酸中毒、循环障碍与休克而危及生命。因本病可以侵犯呼吸道,又称“呼肠病毒”,有40%~50%病人伴有咳嗽等呼吸道症状。过去人们习惯称小儿腹泻为“消化不良”或“肠炎”,近年来统称为腹泻。引起小儿泄泻的原因,主要是感受外邪、内伤饮食、脾胃虚弱等,其病变在脾胃,因胃主腐熟水谷,脾主运化精微,若脾胃受病,则饮食入胃,水谷不化,清浊相干,并走大肠,遂成泄泻。进食过多、过少、不定时的喂养,过早进食大量淀粉类和脂肪类的食品,以及突然更换食物种类,都可引起消化功能紊乱。长期应用大量抗生素导致菌群失调也可以引起细菌性腹泻。小儿腹泻根据其不同病因又可分为“感染性腹泻”与“非感染性腹泻”。感染性腹泻主要指肠道内感染,可由病毒、细菌、真菌等引起;非感染性腹泻往往与喂养、饮食因素和气候变化有关。病毒性腹泻可由病毒引起,尤其以轮状病毒感染多见,好发生于6个月到2岁的婴幼儿,6个月以下小儿因有母亲的抗体,一般很少发病。小儿腹泻的治疗对于轻型腹泻患儿遵循预防或纠正脱水、继续饮食、合理用药的原则,一般很快就能康复。西医对小儿腹泻的治疗,主要对症治疗,补液(口服补液盐),各种止泻剂,抗生素,如大肠杆菌感染选用复方新诺明、痢特灵、氨基苄青霉素等;金黄色葡萄球菌感染可以选用青霉素或红霉素;霉菌感染应选用制霉菌素或克霉唑,虽能达到控制症状的效果,但由于毒副作用大,令患者难于接受。
中医治疗小儿腹泻的药物虽然很多,如中成药:脾可欣、健脾止泻散、肠胃康冲剂等,对那些久泻不愈,或伴有呕吐、吃药困难的患儿,控制症状收效缓慢,很难从根本上解决问题。
发明内容
本发明所要解决的技术问题在于,提供一种配方简单、制作工艺简便,毒副作用小且给药方便,药剂易于制造,成本低廉的新药。本发明中药制剂,精选气味平和的中药,使中药制剂的气味并不浓烈,适合儿童口感,让儿童不至于产生厌烦情绪。本发明采用不同药性的中药材,进行了科学配伍,能达到理想的治疗效果,且安全,毒副作用小,制备简单,能直达病灶,治愈时间短,治愈后不易复发。
为解决上述技术问题,本发明提供一种治疗小儿腹泻的中药组合物,内服药物中各种原料药的重量份数比为:白头翁10~15份,山药10~15份,炒芡实10~15份,石榴皮10~15份,云木香10~15份,肉豆蔻10~15份,白术10~15份,茯苓10~15份,葛根10~15份,薤白10~15份,大腹皮10~15份,黄连10~15份,陈皮10~15份。
所述治疗小儿腹泻的中药组合物,内服药物中症见湿热泻可以加滑石10~15份,苍术10~15份,厚朴10~15份,薏仁10~15份。
所述治疗小儿腹泻的中药组合物,内服药物中症见风寒泻可加加藿香10~15份,马齿苋10~15份,连翘10~15份,防风10~15份。
所述治疗小儿腹泻的中药组合物,内服药物中症见纳差不食、脾肾阳虚泻加焦三仙各10份,鸡内金10~15份,五味子10~15份,丁香10~15份。
所述治疗小儿腹泻的中药组合物,外用药物中各种原料药的重量份数比优选为:小茴香10~15份,肉桂10~15份,葱白10~15份,生麦芽10~15份,大青叶10~15份,细辛10~15份,黄柏10~15份,蒲公英10~15份。
为解决上述技术问题,本发明提供了一种治疗小儿腹泻的中药组合物内服药物的制备方法,其剂型为胶囊剂的制备方法包括:a称取原料药加入水提取2次,成浸膏状,为组分1;
b药渣加乙醇浓缩过滤为浸膏状,为组分2;
c将上述两种浸膏浓缩干燥成干膏,混合粉碎,加糊精适量,混匀,灌装胶囊。
所述步骤a中,可以称取原料药加入5-10倍量的水浸泡1-2小时,提取2次;加热提取1-2小时,浓缩至浸膏状,成为组分1。
所述步骤b中,可以将药渣加60-90%乙醇浸泡0.5-1.5小时,提取两次,每次1-2小时,合并提取液,滤过,浓缩,80-160目滤过,6000-10000转/分钟离心后的上清液,经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为1.35(80℃)的浸膏,加热回流提取2次,每次30分钟~45分钟,提取活性成份,将2次提取液合并静置成浸膏状,作为组分2。
为解决上述技术问题,本发明还提供了一种治疗小儿腹泻的中药组合物外用药物的制备方法,其剂型为贴剂的制备方法包括:
将所述外用药物中各原料药除细辛外加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状药液;将细辛粉碎成细粉加入前述糊状药液中;然后混和凡士林调成膏状,摊于油纸或橡胶膏上,贴敷腹部或肚脐处即可。
所述治疗小儿腹泻的中药组合物,内服药物在使用时可以煎汤剂服用,每日1剂,水煎分两次服,每7天为一疗程;当本中药组合物为丸剂、胶囊剂或片剂使用时,一日三次,每10天为一疗程;外用药物可以煎煮后制成灌肠剂,取汁100mL~200mL,保留灌肠,每次灌入30mL~50mL,以12号输氧管和50mL注射器缓慢注入,保留药液以10min为宜,插入深度为15cm~20cm,1d 2次,4d为1疗程;或制成贴剂贴敷腹部或肚脐处。
肚脐,穴名神阙,为任脉重要穴位,古有“神阙,主治百病,及老人、虚人泄泻如神”之说,脐所在部位又为冲脉经行之处,任督二脉互为表里,统领人体诸经百脉,故脐部通过以上经络与全身诸脏腑器官密切联系。小儿肌肤稚嫩,腹壁单薄,局部用药易于吸收,且无痛苦,中药外敷神阙可达散寒通阳、理气止痛,迅速止痢疾之功。
本发明的中药组合物具有平肝止痛、理气健脾、补脾肺肾、补中益气和升阳止泻的功效,主治脾胃不调,和脾胃虚弱、婴幼儿快速生长发育期,需要的营养多,相对胃肠道的负担较重,加之小儿寒暖不能自调,饮食不能自节,因此,外易受邪气侵袭,内易为饮食所伤引起的小儿腹泻、食少便溏、肢倦乏力、泻后痛缓和反复发作等症;且制作工艺简便,毒副作用小且给药方便,药剂易于制造,成本低廉的新药。本发明为中药制剂,但精选气味平和的中药,使中药制剂的气味并不浓烈,适合儿童口感,让儿童不至于产生厌烦情绪。本发明采用不同药性的中药材,进行了科学配伍,能达到理想的治疗效果,且安全,毒副作用小,制备简单,能直达病灶,治愈时间短,治愈后不易复发。
具体实施方式
小儿腹泻中医又称泄泻,以大便次数增多,粪质稀薄呈水样为主症,属中医学“泄泻”范畴。是儿科常见病之一,两岁以下婴幼儿多见,年龄越小,发病率越高,而且临床症状越重。小儿脾胃脆弱,乳食易伤,筋骨柔弱,风寒易袭,加之先天脾胃虚弱,所以感受外邪,内伤饮食,是小儿泄泻的主要原因,故其病变在脾胃,久之则寝淫其他脏腑。引起腹泻的原因多以感受外邪,内伤饮食,脾胃虚弱者多见。根据大便形状呈水样黄色稀大便,味臭,大便次数多,伴发热,汗出,舌质红,苔多黄腻,辨证为湿热泄泻。为感受湿热之邪,蕴结脾胃,下注大肠,传化失职所致。治拟清热利湿,化湿和中。
引起小儿泄泻的原因,主要是感受外邪、内伤饮食、脾胃虚弱等,其病变在脾胃,因胃主腐熟水谷,脾主运化精微,若脾胃受病,则饮食入胃,水谷不化,清浊相干,并走大肠,遂成泄泻。进食过多、过少、不定时的喂养,过早进食大量淀粉类和脂肪类的食品,以及突然更换食物种类,都可引起消化功能紊乱。长期应用大量抗生素导致菌群失调也可以引起细菌性腹泻。本发明所阐述的药物长期服用没有毒副作用,原材料价廉质优易得。
苍术能补气健脾和燥湿利水,用于脾胃虚寒之腹满泄泻;白术能平肝止痛和敛阴止汗,用于肝脾不调、腹痛泄泻等;茯苓能利水渗湿和健脾安神,用于脾虚泄泻;山药薏仁能益气养阴和补脾肺肾。用于脾胃虚弱和止泻等;陈皮能理气健脾,用于肝气乘脾,腹痛泄泻等;芡实,云木香能敛肺滋肾和涩精止泻,用于久泻不止;葛根能生津止渴和升阳止泻;诸药配伍,共奏清热解毒、疏散风热、利咽消肿和滋阴润肺之效。方中白头翁,马齿苋,五味子益气敛阴,助补气生阴之力;连翘滋阴润燥、清热除烦;茯苓,补脾益肾,载药上行,薤白,大腹皮,厚朴使药力上行,可行气血,使诸药滋而不腻,补不留瘀;滑石化瘀除湿;陈皮开胃消食,葛根清热消烦,焦三仙和鸡内金健脾消食,是治疗厌食,积食的良药;小茴香、肉桂、肉豆蔻均是进补的良药;细辛、大青叶均是散热祛湿的良药。诸药配伍可以达到迅速清热解毒,凉血止痢,燥湿杀虫、行气止痛,健脾消食的功效。
白头翁味苦,性寒;归胃、大肠经;具有清热解毒,凉血止痢,燥湿杀虫的功效;主治热毒痢疾,鼻衄,血痔,带下,阴痒,痈疮,瘰疬白头翁为治阿米巴痢疾的要药,单用较大剂量,即有效果。常用成方白头翁汤,即以本品为主药,配合黄连、黄柏、秦皮而成,既可用治阿米巴痢疾,也可用治菌痢。《本草正义》载其:白头翁味微苦而淡,气清质轻,《本经》虽谓苦温,然以主治温疟狂易,而仲景且以专治热利下重,则必非温药可知。其主热毒滞下,虽曰苦固能泄,而升举脾胃清气,使不陷下,则里急后重皆除,确是此药之实在真谛。
云木香辛、苦,温。归脾、胃、大肠、三焦、胆经。行气止痛,健脾消食。用于胸脘胀痛,泻痢后重,食积不消,不思饮食。云木香实肠止泻。用于泄泻腹痛。对胃肠道有兴奋或抑制双向作用,有促进消化液分泌、利胆、松弛气管平滑肌、抑菌、利尿、等作用。
薤白辛、苦,温。归肺、胃、大肠经。理气,宽胸,通阳,散结。治胸痹心痛彻背,脘痞不舒,干呕,泻痢后重,疮疖。通阳散结,行气导滞。用于胸痹疼痛,痰饮咳喘,泄痢后重。《本草拾遗》载其:调中,主久利不瘥,大腹内常恶者,但多煮食之。
大腹皮味辛;性微温。归脾;胃;大肠;小肠经。现代研究,该品有兴奋胃肠道平滑肌、促胃肠动力作用,并有促进纤维蛋白溶解等作用。《开宝本草》:主冷热气攻心腹,大肠壅毒,痰膈,醋心。并以姜盐同煎,入疏气药良。《纲目》:降逆气,消肌肤中水气浮肿,脚气壅逆,瘴疟痞满,胎气恶阻胀闷。《本草再新》:泻肺,和胃气,利湿追风,宽肠消肿,理腰脚气,治疟疾泻痢。
黄连清热燥湿,泻火解毒。用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。酒黄连善清上焦火热。用于目赤,口疮。姜黄连清胃和胃止呕。用于寒热互结,湿热中阻,痞满呕吐。萸黄连舒肝和胃止呕。用于肝胃不和,呕吐吞酸。用于湿热内蕴、肠胃湿热、呕吐、泻痢等症。配黄芩、大黄等,能治湿热内蕴之证。对湿热留恋肠胃,常配合半夏、竹茹;配木香、黄芩、葛根等以治泻痢。
厚朴苦,辛,温。归脾、胃、肺、大肠经。功效燥湿消痰,下气除满。湿阻中焦,脘腹胀满。本品苦燥辛散,能燥湿,又下气除胀满,为消除胀满的要药。常与苍术、陈皮等同用,如平胃散(《和剂局方》)食积气滞,腹胀便秘。本品可下气宽中,消积导滞。常与大黄、枳实同用,如厚朴三物汤(《金匮要略》)。若热结便秘者,配大黄、芒硝、枳实,以达峻下热结,消积导滞之效,即大承气汤(《伤寒论》)。
炒芡实固肾涩精,补脾止泄。治遗精,淋浊,带下,小便不禁,大便泄泻。健脾止泻:用于脾虚泄泻,常配山药、白术补中益气,为滋养强壮性食物,和莲子有些相似,但芡实的收敛固精作用比莲子强,适用于慢性泄泻和小便频数,梦遗滑精,妇女带多腰酸等。慢性泄泻,包括慢性肠结核,五更泄泻等。《本草从新》:补脾固肾,助气涩精。
五味子温;酸、甘;归肺、心、肾经。收敛固涩,益气生津,补肾宁心。用于久嗽虚喘,梦遗滑精,遗尿尿频,久泻不止,自汗,盗汗,津伤口渴,短气脉虚,内热消渴,心悸失眠。果实作中药功能益气生津、敛肺滋肾、止泻、涩精、安神,可治久咳虚喘、津少口干、遗精久泻、健忘失眠等症。五味子果实作中药功能益气生津、敛肺滋肾、止泻、涩精、安神,可治久咳虚喘、津少口干、遗精久泻、健忘失眠等症。药理试验证明能调节中枢神经系统的兴奋和抑制过程,促进肌体代谢,调节胃液和胆液分泌,对肝炎恢复期转氨酶升高者有降低作用。《本草汇言》:五味子,敛气生津之药也。故《唐本草》主收敛肺虚久嗽耗散之气。凡气虚喘急,咳逆劳损,精神不足,脉势空虚,或劳伤阳气,肢体赢瘦,或虚气上乘,自汗频来,或精元耗竭,阴虚火炎,或亡阴亡阳,神散脉脱,以五味子治之,成用其酸敛生津,保固元气而无遗泄也。然在上入肺,在下入肾,入肺有生津济源之益,入肾有固精养髓之功。
白术味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。《药性论》载其:君,味甘,辛,无毒。能主大风痹,多年气痢,心腹胀痛,破消宿食,开胃,去痰涎,除寒热,止下泄。主面光悦,驻颜,去黑。治水肿胀满,吐呕逆,腹内冷痛,吐泻不住,及胃气虚冷痢。
山药味甘、性平,入肺、脾、肾经;不燥不腻,有健脾补肺、益胃补肾、固肾益精、聪耳明目、助五脏、强筋骨、长志安神、延年益寿的功效;主治脾胃虚弱、倦怠无力、食欲不振、久泄久痢、肺气虚燥、痰喘咳嗽、肾气亏耗、腰膝酸软、下肢痿弱、消渴尿频、遗精早泄、带下白浊、皮肤赤肿、肥胖等病症。《本草纲目》概括五大功用“益肾气,健脾胃,止泄痢,化痰涎,润皮”。山药煮粥或者用冰糖煨熟后服用,对身体差、肠炎、肾亏等慢性病均有疗效。补益脾胃:治疗脾胃虚弱、泄泻、体倦、食少、虚汗。益肺滋肾:本品不寒不燥,味甘质润,可治疗肺肾虚损的消渴、遗精、带下等病证。被誉为神仙药。
陈皮温;辛、苦;归脾、肺经陈皮的苦味物质是以柠檬苷和苦味素为代表的“类柠檬苦素”,这种类柠檬苦素味平和,易溶解于水,有助于食物的消化。陈皮用于烹制菜肴时。其苦味与其他味道相互调和,可形成独具一格的风味。陈皮含有挥发油、橙皮甙、维生素B、C等成分,它所含的挥发油对胃肠道有温和刺激作用,可促进消化液的分泌,排除肠管内积气,增加食欲。陈皮也是一味常用中药,具有通气的健脾、燥湿化痰、解腻留香、降逆止呕的功效。
肉豆蔻收涩药;温里药;行气药。性辛味苦,温。归脾;胃;大肠经。功效主治温中涩肠;行气消食。用于虚泻;冷痢;脘腹胀痛;食少呕吐;宿食不消。《日华子本草》:调中,下气,止泻痢,开胃,消食。皮外络,下气,解酒毒,治霍乱。《开宝本草》:温中,治积冷心腹胀痛,霍乱中恶,呕沫,冷气,消食止泄,小儿乳霍。《纲目》:暖脾胃,固大肠。
石榴皮有涩肠止泻,止血,驱虫的功效。《药性论》载其:″治筋骨风,腰脚不遂,步行挛急疼痛。主涩肠,止赤白下痢。取汁止目泪下,治漏精。″《本草拾遗》载其:″主蛔虫。煎服。″《滇南本草》载其:″治日久水泻,同炒砂糖煨服,又治痢脓血,大肠下血。″″同马兜铃煎治小儿疳虫。″体外实验表明:石榴皮对大肠杆菌、宋内痢疾杆菌、变形杆菌、伤寒杆菌、副伤寒杆菌、绿脓杆菌、霍乱弧菌等7种革兰阴性肠内致病菌皆有抑制作用.在试管内,石榴皮煎剂对4种痢疾杆菌皆有抗菌作用,但程度上有所差异,以对志贺痢疾杆菌作用最强(1∶320),对施氏、弗氏痢疾杆菌次之(1∶80),而对宋内痢疾杆菌作用较差(1∶20).平板法的抗菌效果低于试管法.其抗菌作用机制与其所含多量鞣酸有关
葛根解表退热,生津,透疹,升阳止泻。用于外感发热头痛、高血压颈项强痛、口渴、消渴、麻疹不透、热痢、泄泻。《本草纲目》载:葛根,性凉、气平、味甘,具清热、降火、排毒诸功效。现代医学研究表明:葛根中的异黄酮类化合物葛根素对高血压、高血脂、高血糖和心脑血管疾病有一定疗效。升举阳气,止渴止泻葛根轻清升散,药性升发,柳举阳气,鼓舞机体正气上升,津液布行。升发脾胃清阳空气而止渴,止泻痢。故常用于治疗内热消渴,麻疹透发不畅,腹泻、痢疾等病症。
焦三仙是三味药,即焦麦芽、焦山楂、焦神曲。这三味药均有良好的消积化滞功能,但又有各自不同的特点。焦麦芽有很好的消化淀粉类食物的作用;焦山楂善于治疗肉类或油腻过多所致的食滞;焦神曲则利于消化米面食物。三药合用,能明显地增强消化功能。因此,临床上医生常将三药合用并称为“焦三仙”。
麦芽,经大麦发芽而成,将麦芽置锅内微炒至黄色,喷洒清水,取出晒干,即为焦麦芽。焦麦芽具有健脾和胃、舒肝化滞之功,用于治疗食积不消、脘腹胀满、食欲不振、呕吐泄泻等症。现代研究认为,麦芽中富含淀粉分解酶、转化糖酶、脂化酶、维生素B等,有良好的助消化作用。
山楂,切片晒干,置锅内用武大炒至外面焦褐色、内部黄褐色为度、喷洒清水,取出晒干,即为焦山楂。口服山楂能增加消化酶,促进脂肪的分解和消化,对因吃肉类或油腻过多所致脘腹胀满、嗳气、不思饮食、腹痛、腹泻者,疗效尤佳。此外,现代药物试验表明,山楂有缓慢而持久的降低血压的功效,还可降低胆固醇和甘油三酯,防止动脉粥样硬化,而且还可舒张冠状动脉,增加心肌收缩力,对抗心律失常。因此,有利于防治高血压、高血脂、动脉硬化及冠心病。
神曲,为全麦粉和其他药物(青蒿、苍耳,辣蓼、杏仁、赤小豆等芽)混合后经发酵而成的加工品。取神曲置锅内炒至外表呈焦黑色、内部焦黄色,取出,喷洒些消水,放凉,即为焦神曲。神曲经发酵而成,凡发酵之品都有健脾胃助消化的作用,因此,对于饮食内伤所致的消化的不良、胸痞腹胀颇有效验。
鸡内金甘,寒。归脾、胃、小肠、膀胱经。消食健胃,涩精止遗。鸡内金含胃激素、角蛋白、氨基酸以及微量胃蛋白酶、淀粉酶等。口服鸡内金粉后,胃液的分泌量、酸度和消化力均增高,胃运动加强、排空加快。其酸提取液或煎剂能加速从尿中排除放射性锶。
茯苓甘、淡,平。归心、肺、脾、肾经。功能利水渗湿,健脾宁心。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。渗湿利水,益脾和胃,宁心安神。治小便不利,水肿胀满,痰饮咳逆,呕哕,泄泻,遗精,淋浊,惊悸,健忘。《本经》载其:″主胸胁逆气,忧恚惊邪恐悸,心下结痛,寒热烦满,咳逆,口焦舌干,利小便。″《别录》:″止消渴,好睡,大腹,淋沥,膈中痰水,水肿淋结。开胸腑,调脏气,伐肾邪,长阴,益气力,保神守中。″《药性论》:″开胃,止呕逆,善安心神。主肺痿痰壅。治小儿惊痫,心腹胀满,妇人热淋。″
肉桂性大热,味辛、甘。是补火助阳,引火归源,散寒止痛,活血通经的良药。用于阳痿、宫冷、心腹冷痛、虚寒吐泻、经闭、痛经、温经通脉。主治肾阳不足;命门火畏寒肢冷;腰膝酸软;阳痿遗精;小便不利或频数;短气喘促;浮肿尿少诸证;命门火衰;火不归源;戴阳;格阳;及上热下寒;面赤足冷;头晕耳鸣;口舌糜破;脾肾虚寒;脘腹冷痛;食减便溏;肾虚腰痛;寒湿痹痛;寒疝疼痛;宫冷不孕;痛经经闭;产后瘀滞腹痛;阴疽流注;或虚寒痈疡脓成不溃;或溃后不敛。《别录》载其:主心痛,胁风,胁痛,温筋,通脉,止烦、出汗。主温中,利肝肺气,心腹寒热、冷疾,霍乱转筋,头痛,腰痛,止唾,咳嗽;能堕胎,坚骨节,通血脉,理疏不足;宣导百药,无所畏。
防风味辛、甘,性微温。归膀胱、肝、脾经。祛风解表,胜湿止痛,止痉。主治外感表证,风疹瘙痒,风湿痹痛,破伤风。常配合羌活、桂枝、姜黄防风能升脾阳而止泻。临床常见有因脾胃之虚,怠惰嗜卧,肢体酸疼,大便溏泄,小溲频数者,用升阳益胃汤(《脾胃论》),每奏捷效。若因外伤风邪,肝木乘脾,完谷不化,而泄泻者,用痛泻要方(《医方集解》引刘草窗方),取防风能舒脾泻肝胜湿,为引经之要药。防风配枳实(壳)能通便。方如《太平圣惠方》搜风顺气丸用防风升脾之清气,配枳壳、大黄以宽肠顺气,治中风而引起的风秘、气秘,使清阳升而浊阴降。王好古用防风合苍术、甘草为末(神术散),加生姜、葱白煎服,治内伤冷饮,外感寒邪而无汗者。临床取本方加枳壳(实)、麦芽治心下虚痞,以行气除满,消食去滞。
滑石甘、淡,寒。归膀胱、肺、胃经。功能与主治利尿通淋,清热解暑,祛湿敛疮。用于热淋,石淋,尿热涩痛,暑湿烦渴,湿热水泻;外治湿疹,湿疮,痱子。用于小便不利、淋沥涩痛等症,可配车前子、木通等品;用于湿热引起的水泻,可配合茯苓、薏苡仁、车前子等同用。
连翘苦,微寒。归肺、心、小肠经。功能是清热解毒,消肿散结。用于痈疽,瘰疬,乳痈,丹毒,风热感冒,温病初起,温热入营,高热烦渴,神昏发斑,热淋尿闭。连翘药用部分主要是果实。它的果壳,即“芩翘解毒丸”中的“翘”。含有连翘酚、香豆精、齐墩果酸、皂甙、维生素P等。具有清热、解毒、散结排脓等功效。主治温热、疮疡、瘰疬、丹毒、班疹、流感,用果实水煎服,或加入方剂中。常用于风热感冒。性味功能:中药味苦,性微寒。清热解毒,散结消肿。蒙药味苦,性凉。清“协日”,止泻。主治:中药治热病初起,风热感冒,发热,心烦,咽喉肿痛,斑疹,丹毒,瘰疬,痈疮肿毒,急性肾炎,热淋。蒙药治黄疸,肠刺痛,“协日”病,肠热。神农本草经》:主寒热,鼠痿,瘰疬,痈肿,恶疮,瘿瘤,结热,蛊毒。
薏仁是常用的中药.又是普遍、常吃的食物,性味甘淡微寒,有利水消肿、健脾去湿、舒筋除痹、清热排脓等功效,为常用的利水渗湿药。薏苡仁油低浓度时对家兔离体肠管呈兴奋作用,高浓度时先呈一时性兴奋而后麻痹;能使家兔及豚鼠的子宫紧张度增加,振幅增大,此兴奋作用可被肾上腺素所翻转.薏苡素对家兔肠管的运动有抑制作用。
藿香味辛;性微温。归肺;脾;胃经。祛暑解表;化湿和胃。用于夏令感冒;寒热头痛;胸脘痞闷;呕吐泄泻;妊娠呕吐;鼻渊;手;足癣《药品化义》:藿香,其气芳香,善行胃气,以此调中,治呕吐霍乱,以此快气,除秽恶痞闷。且香能和合五脏,若脾胃不和,用之肋胃而进饮食,有醒脾开胃之功。辛能通利九窍,若岚瘴时疫用之,不使外邪内侵,有主持正气之力。凡诸气药,独此体轻性温,大能卫气,专养肺胃。但叶属阳,为发生之物,其性锐而香散。
马齿苋味酸;性寒清热解毒;凉血止痢;除湿通淋。该品有清热解毒、祛湿止带功效,适用于湿热下注、带下色黄、黏稠味臭、小便短黄、口渴口苦、舌红苔黄、脉滑者,亦可用于湿热泄泻、痢疾等。
丁香温中、暖肾、降逆治呃逆、呕吐、反胃、痢疾、心腹冷痛、痃癖、疝气、癣症。治疗牙痛、支气管炎,神经痛、胃酸,抗呼吸系统及泌尿系统感染,减轻痢疾所造成之不适与疼痛,改善衰弱体质与贫血,催情(性无能、冷感),驱虫。促进血液循环,治疗皮肤溃疡及伤口发炎,治疗疥癣,改善粗糙肌肤。
小茴香有散寒止痛,理气和中的功效。用于寒疝腹痛,睾丸偏坠,痛经,少腹冷痛,脘腹胀痛,食少吐泻,睾丸鞘膜积液。盐小茴香暖肾散寒止痛。对胃肠运动的影响:小茴香对家兔在体肠蠕动有促进作用.茴香脑2.5×10-5g/m l对小鼠离体肠管有兴奋作用,浓度增高则出现松弛作用,松弛的肠管对乙酰胆碱亦无反应.
葱白主治感冒风寒;阴寒腹痛;二便不通;痢疾;疮痈肿痛;虫积腹痛。《本草经疏》:葱,辛能发散,能解肌,能通上下阳气,故外来怫郁诸证,悉皆主之。伤寒寒热,邪气并也;中风面目肿,风热郁也;伤寒骨肉痛,邪始中也。喉痹不通,君相二火上乘于肺也,辛凉发散,得汗则火自散而喉痹通也。肝开窍于目,散肝中邪热,故云归目。除肝邪气,邪气散则正气通,血自和调而有安胎安中利五脏之功矣。其曰益目睛,杀百药毒者,则是辛润利窍而兼解散通气之力也。
生麦芽行气消食,健脾开胃,退乳消胀。用于食积不消,脘腹胀痛,脾虚食少,乳汗郁积,乳房胀痛,妇女断乳,生麦芽健脾和胃通乳。用于脾虚食少,乳汗郁积。炒麦芽行气消食回乳。用于食积不消,妇女断乳。焦麦芽消食化滞。用于食积不消,脘腹胀痛。
大青叶主要用于热毒发斑、丹毒、咽喉肿痛、口舌生疮、疮痈肿毒等症。近年来此药在临床上广泛应用,除可用治上述诸症外,又可用于痰热郁肺、咯痰黄稠;尤常用于流行性乙性脑炎,既可单味应用于预防,又可配合柴胡、银花、连翘、板蓝根、玄参、生地等,能清解气分、营分的热毒,可用治各种乙脑,而以偏热型较为合适。《本草正》:″治瘟疫热毒发狂,风热斑疹,痈疡肿痛,除烦渴,止鼻衄、吐血,杀疳蚀、金疮箭毒。凡以热兼毒者,皆宜蓝叶捣汁用之。″
细辛味辛,温祛风,散寒,行水,开窍。治风冷头痛,鼻渊,齿痛,痰饮咳逆,风湿痹痛。《药性论》载:治咳逆上气,恶风,风头,手足拘急,安五脏六腑,添胆气,去皮风湿庠,能止眼风泪下,明目,开胸中滞,除齿痛,主血闭,妇人血沥腰痛,对风热头痛最有疗效。
黄柏清热燥湿,泻火除蒸,解毒疗疮。用于湿热泻痢,黄疸,带下,热淋,脚气,痿辟,骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒。黄柏滋阴降火。用于阴虚火旺,盗汗骨蒸。《中国药典》载黄柏清热燥湿之力,与黄芩、黄连相似,但以除下焦之湿热为佳。
苍术燥湿健脾,祛风散寒,明目。用于脘腹胀满,泄泻水肿,脚气痿躄,风湿痹痛,风寒感冒,夜盲。用于湿阻脾胃、脘腹胀满,寒湿白带,湿温病以及湿热下注、脚膝肿痛、痿软无力。治湿阻脾胃,而见脘腹胀满、食欲不振、倦怠乏力、舌苔白腻厚浊等症,常与厚朴、陈皮等配伍应用;治寒湿白带,可配白芷同用。如湿热白带,又可配知母、苦参、墓头回;湿热下注、脚膝肿痛、痿软无力,可配黄柏、牛膝、薏苡仁等同用;湿温病证可配石膏、知母等同用。
蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分,有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等,有丰富的营养价值,可生吃、炒食、做汤,是药食兼用的植物。蒲公英属菊科属多年生草本植物。是药食兼用的植物。据《本草纲目》记载,它性平味甘微苦,有清热解毒、消肿散结及催乳作用,对治疗乳腺炎十分有效。无论煎汁口服,还是捣泥外敷,皆有效验。此外,蒲公英还有利尿、缓泻、退黄疸、利胆等功效,被广泛应用于临床。《本草纲目》有句云:“蒲公英嫩苗可食,生食治感染性疾病尤佳。”《神农本草经》、《唐本草》、《中药大辞典》等历代医学专著均给以高度评价。蒲公英含有丰富的营养价值,含有蛋白质、脂肪、碳水化合物、微量元素及维生素等。
本发明蜜炼丸剂的制作过程为:白头翁1000g,山药1000g,炒芡实1000g,石榴皮1000g,云木香1000g,肉豆蔻1000g,白术1000g,茯苓1000g,葛根1000g,薤白1000g,大腹皮1000g,黄连1000g,陈皮1000g。
把药材加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸30分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在75℃,烘干后冷却成粉末状与蜂蜜适量混和在一起搓成细条;以每5g为一丸腊封包装。
本发明当湿热泻时胶囊剂的制作过程为:取滑石1000g,苍术1000g,厚朴1000g,薏仁1000g,白头翁1000g,山药1000g,炒芡实1000g,石榴皮1000g,云木香1000g,肉豆蔻1000g,白术1000g,茯苓1000g,葛根1000g,薤白1000g,大腹皮1000g,黄连1000g,陈皮1000g。加入5-10倍量的水浸泡1-2小时,提取2次;加热提取1-2小时,浓缩至浸膏状,成为组分1;剩余药渣加60-90%乙醇浸泡0.5-1.5小时,提取两次,每次1-2小时,合并提取液,滤过,浓缩,80-160目滤过,6000-10000转/分钟离心后的上清液,经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为1.35(80℃)的浸膏,加热回流提取2次,每次30分钟~45分钟,提取活性成份,将2次提取液合并静置成浸膏状,作为组分2。将上述两种浸膏浓缩干燥成干膏,混合粉碎,加糊精适量,混匀,灌装胶囊
本发明风寒泻时片剂制备方法:藿香1000g,马齿苋1000g,连翘1000g,防风1000g,白头翁1000g,山药1000g,炒芡实1000g,石榴皮1000g,云木香1000g,肉豆蔻1000g,白术1000g,茯苓1000g,葛根1000g,薤白1000g,大腹皮1000g,黄连1000g,陈皮1000g。
先将药材放入10倍量乙醇中,加热回流提取2次,每次45分钟,提取活性成份,将2次提取液合并静置。再将药渣加10倍量水,加热回流提取3次,每次1小时,将3次提取液合并;合并上述两种提取液,减压回收乙醇并浓缩至药液浓度为0.5g生药/mL,抽滤后,滤液的相对密度约为1.06(20℃);上述滤液经体积为10L的大孔吸附树脂柱,先用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除溶剂,得到原料药液;加入淀粉压制成片剂。
本发明症见纳差不食、脾肾阳虚泻时冲剂制备方法:焦三仙各1000g,鸡内金1000g,五味子1000g,丁香1000g,白头翁1000g,山药1000g,炒芡实1000g,石榴皮1000g,云木香1000g,肉豆蔻1000g,白术1000g,茯苓1000g,葛根1000g,薤白1000g,大腹皮1000g,黄连1000g,陈皮1000g,所述组份按配比混合,投入粉碎机粉碎成细粉,细粉过筛后放入耐酸碱浸渍锅内,在常温下,与乙醇共同浸渍10~20天,将浸渍好的液体及药渣进行压榨过滤,分离后取滤液,加热浓缩至糊状,调入适量糊精放入烘箱,控制在100℃,烘干后冷却制成颗粒冲剂。
外用药物贴剂的制备方法:取小茴香1000g,肉桂1000g,葱白1000g,生麦芽1000g,大青叶1000g,黄柏1000g,蒲公英1000g;将上述外用药物的原料药加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状药液;将细辛1000g粉碎成细粉加入前述糊状药液中;然后混和凡士林调成膏状,摊于油纸或橡胶膏上即可;可贴敷于腹部或肚脐处。
外用药物也可以直接煎煮后制成灌肠剂,取汁100mL~200mL,保留灌肠,每次灌入30mL~50mL,以12号输氧管和50mL注射器缓慢注入,保留药液以10min为宜,插入深度为15cm~20cm,1d 2次,4d为1疗程;或制成贴剂贴敷腹部或肚脐处。
肚脐,穴名神阙,为任脉重要穴位,古有“神阙,主治百病,及老人、虚人泄泻如神”之说,脐所在部位又为冲脉经行之处,任督二脉互为表里,统领人体诸经百脉,故脐部通过以上经络与全身诸脏腑器官密切联系。小儿肌肤稚嫩,腹壁单薄,局部用药易于吸收,且无痛苦,中药外敷神阙可达散寒通阳、理气止痛,迅速止痢疾之功。
药理药效学实验:
1、急性毒性试验
应用小鼠进行急性毒性实验表明:小鼠口服灌胃本发明的中药组合物的内服药物胶囊剂,在488.8g生药/kg剂量下,给药后小鼠出现轻微活动减少,1小时左右恢复正常,给药后连续观察7天,无一动物死亡,其全身状况、饮食、摄水、小便和体重增长均正常,实验结果表明:小鼠口服灌胃本发明的中药组合物胶囊剂的最大给药量为488.8g生药/kg/d(LD 50>488.8g生药/kg)。本发明的中药组合物每日临床用药总量为0.1g生药/kg/d;按体重计,小鼠灌胃本发明的中药组合物的耐受量为临床病人的4888倍。提示该药急性毒性低,临床用药安全。
2、长期毒性试验
选用SD大鼠,给予不同浓度(18.0、6.0、2.0g生药/kg)的本发明的中药组合物内服药物丸剂,每天灌胃一次,连续90天,末次给药后24小时各组活杀1/2动物(雌雄各半),其余1/2动物继续观察2周后活杀。试验期间观察动物的外观、一般行为、摄食量、体重变化,给药后90天和停药2周进行血液学(RBC、HB、网织红细胞、PLT、CT、WBC及分类)和血液生化(AST、ALT、ALP、Glu、BUN、Crea、TP、T.BIL、ALB、CHOL)、尿液生化、脏器系数、病理组织学等指标检查。试验结果表明:本发明的中药组合物在高、中、低剂量组动物一般状态良好,外观体征、行为活动、进食量和体重增长均无异常变化;三个剂量组及对照组血液学检查、血液生化学、尿液生化检查均在正常范围,组间无显著差异;各组主要脏器组织病理学检查未见明显异常。上述指标停药2周后也未见改变。本试验用药剂量分别为临床用药剂量的180、60、20倍,根据试验结果本发明的中药组合物在高、中、低三个剂量(18.0、6.0、2.0g生药/kg)连续90天给药对大鼠无明显影响,无明确的毒性靶器官和敏感指标,恢复期观察也未见延迟性毒性反应,提示本发明的中药组合物临床应用的剂量安全性较高。
3、动物局部刺激试验:
本发明外用药物贴剂的豚鼠皮肤过敏试验和灌肠剂大鼠直肠用药刺激性试验。结果表明:皮肤过敏试验,高剂量组0.8g(药粉)/kg、低剂量组0.1g(药粉)/kg,分别相当于拟临床人用量[0.04g(药粉)/kg]的20倍、2.5倍,经皮肤给药,均未见动物产生变态反应;直肠用药刺激性试验高剂量组5.0g(药粉)/kg,低剂量组3.2g(药粉)/kg,分别相当于拟临床人用量的125、80倍,在规定的时间内观察直肠粘膜均无充血、水肿等现象,病理组织学检查与空白对照组比较无明显差异,未见出现明显的刺激性反应,每组留存的部分动物其全身状况,体重、呼吸、循环、中枢神经系统及四肢活动等,均无明显异常反应。
本发明的中药制剂(内服药物胶囊剂)的疗效由下面的药效学试验与临床预试证明:
一.对蓖麻油所致小鼠泄泻模型的影响
取ICR小鼠40只,雌雄各半,随机分成模型对照组、思密达组、本发明(内服药物胶囊剂)高剂量组、低剂量组。按组分别灌胃给予相应药物0.2ml/10g B.W.,模型组给予等体积生理盐水,每日一次,连续三天。末次给药40分钟后,每只动物灌胃给予0.2ml蓖麻油。然后将小鼠放入正下方放有滤纸的单元隔离笼内,每格一只。观察指标:湿粪计数;每单元格正下方铺一10cm×10cm面积的滤纸作湿粪计数。以湿粪粒数反应泄泻程度,前1~6小时每小时更换滤纸一次,7~24小时换纸一次,记录24小时内各只动物的累积湿粪总数,与模型对照组比较,用SPSS软件进行组间t检验。结果见表一。
表一 对蓖麻油所致泄泻的止泻作用(X±SD)
| 组别 | 动物数(只) | 给药剂量(g/kg) | 24h稀便粒数 |
| 模型对照组 | 10 | - | 6.9±3.67 |
| 思密达组 | 10 | 0.48 | 2.80±2.30** |
| 本发明高剂量 | 10 | 0.66 | 0.50±1.08*** |
| 本发明低剂量 | 10 | 0.33 | 1.40±1.35*** |
注:与模型对照组比较,**P<0.01,***P<0.001
从表一可见,本发明药物在0.33g/kg能显著抑制蓖麻油所致小鼠泄泻。
二.对小肠推进运动试验
取ICR小鼠40只,雌雄各半,随机分成正常对照组、易蒙停组、本发明高剂量组、低剂量组。按组分别灌胃分别给予相应药物0.2ml/10gB.W.,正常对照组给予等体积生理盐水,每日一次,连续四天。各组小鼠在给药后第三天开始禁食24小时。实验第四天,给药后1小时,灌胃5%活性炭泥悬液0.2ml/10gB.W.。20分钟后,脱颈椎处死动物,打开腹腔,分离肠系膜,剪取上至幽门,下至回盲部之间的肠管,置于平底托盘上,轻轻将小肠拉成直线,测量肠管长度作为“小肠总长度”,从幽门至墨汁前沿的距离作为“墨汁在肠内推进距离”。计算墨汁推进百分率,用SPSS软件进行组间t检验。结果见表二。
表二v 对小肠推进运动的影响(X±SD)
注:与正常对照组比较,**P<0.01,***P<0.001。
由表二可见,本发明和易蒙停对小肠推进功能均有明显抑制作用。
三.体外抗菌试验
采用琼脂二倍稀释法测定本发明对常见致病菌的最低抑菌浓度(MIC)。将受试菌接种于MH肉汤培养基中,35℃培养18小时后,调整其浊度达到0.5麦氏比浊管标准的浊度,菌含量约为108CFU/ml。用无菌生理盐水稀释1∶10(含菌量约107CFU/ml)。分别取已稀释为系列浓度的药液2ml加入作好标记的平板内,再取融化后已冷至50℃左右的MH琼脂培养基18ml加到平板内(药物∶琼脂=1∶9),使药物和培养基充分混匀。药物最终浓度分别为200、100、50、......0.78、0.39mg/ml。将已制备好的菌悬液用接种环接种于含药平板上,于35℃培养18小时观察结果,菌落生长被完全抑制的最低药物浓度为该药对检测菌的MIC。单一菌生长可忽略不计。试验同时设药物对照和菌株生长对照。结果见表三。
表三体外抑菌试验结果
| 菌株 | 最低抑菌浓度(MIC)(mg/ml) |
| 福氏痢疾杆菌 | 4.135 |
| 甲型副伤寒杆菌 | 11.8 |
| 乙型副伤寒杆菌 | 27 |
| 绿脓杆菌 | 5.95 |
| 大肠杆菌 | 51 |
| 肠炎杆菌 | 23 |
| 金黄色葡萄球菌 | 6.18 |
从表三可见,本发明药物对福氏痢疾杆菌、甲型副伤寒杆菌、乙型副伤寒杆菌、大肠杆菌、绿脓杆菌、金黄色葡萄球菌、肠炎杆菌均有一定抗菌作用。
临床资料
1临床资料
1.1一般资料:将161例腹泻患儿,均符合《中国腹泻病诊断治疗方案》中的诊断标准,随机分为治疗组和对照组。治疗组101例中,男58例,女43例;年龄<12个月43例,12-24个月36例,24-36个月22例,轻型腹泻22例,中型腹泻48例,重型腹泻30例;中医分型:湿热泻45例,风寒泻26例,脾虚肾阳虚泻30例。对照组60例中,男32例,女28例;年龄<12个月22例,12-24个月18例,24-36个月20例,轻型腹泻12例,中型腹泻32例,重型腹泻16例;中医分型:湿热泻24例,风寒泻17例,脾虚肾阳虚泻19例。
1.2中医辨证分型
1.2.1湿热泻:泻下急迫,或如水注,粪便色黄,或夹粘液,气味殊臭,肛门灼热,时感腹痛,伴发热,烦躁口渴,食欲不振,肢体困倦,小便短黄。舌红,苔黄腻;脉滑数。
1.2.2风寒泻:泄泻清稀,中多泡沫,臭气不甚,肠鸣腹痛,伴发热,鼻塞清涕,苔薄白,脉浮紧。
1.2.3脾虚肾阳虚泻:大便稀薄,食后作泻,时泻时止,久泻不愈,泻下
水谷不化,带有奶瓣,面色萎黄,肌肉消瘦,神疲倦怠,睡卧露睛。食入即泻,完谷不化,或见脱肛,精神委靡,面色苍白,形寒肢冷。舌淡,苔白;脉弱无力。
2治疗方法
2.1治疗组辨证敷脐,并配合常规治疗分为湿热泄、风寒泄,脾虚肾阳虚三种药物。将以上药物分别研粉,贮瓶备用,每次辨证敢药20g,用温水调成一厚约2mm,周长30cm的薄饼,敷于患儿脐周,24h换药1次,连用3天。
2.2对照组:丁桂儿脐贴敷脐配合常规治疗
将亚宝牌丁桂儿脐贴(山西亚宝药业集团股份有限公司,曾用名:宝宝一贴灵)敷于患儿脐部,24h换药1次,连用3天。
2.3常规治疗:两组患儿根据脱水情况给予口服补液盐(ORS液)补液或静脉补液治疗,纠正酸碱失衡及电解质紊乱。伴细菌感染合理应用抗生素。不使用收敛止泻药及微生态制剂。治疗期间进食清淡易消化的食物,以乳食为主的患儿可换无乳糖的乳制品,呕吐频繁者可暂禁食不禁水。两组均治疗3天后进行疗效评定。
3疗效对比
3.1疗效标准:痊愈:治疗3天内粪便性状及次数恢复正常,全身症状消失;有效:治疗3天内粪便性状及次数明显好转,全身症状明显改善;无效:治疗3天内粪便性状、次数及全身症状无好转甚至恶化。
3.2结果:两组疗效比较见表1。表1显示治疗组总有效率、痊愈率均显著高于对照组(P均<0.05)。治疗组中湿热泻及风寒泻有效率,痊愈率均明显高于对照组(P均<0.01),治疗组中脾虚泻,脾肾阳虚泻有效率、痊愈率与对照组相比,无显著性差异(P>0.05)。
表1 两组疗效比较[n(%)]
| 组别 | N | 痊愈 | 有效 | 无效 | 总有效率(%) |
| 治疗组 | 101 | 76 | 16 | 9 | 91.1 |
| 湿热泻 | 45 | 32(71) | 8(17.7) | 5(11.1) | 88.9 |
| 风寒泻 | 26 | 21(80.7) | 4(15.4) | 1(3.8) | 96.2 |
| 脾虚肾阳虚泻 | 30 | 23(76.7) | 4(13.3) | 3(10) | 90 |
| 对照组 | 60 | 31 | 16 | 13 | 78.3 |
| 湿热泻 | 24 | 12(50) | 7(29.1) | 5(20.8) | 79.2 |
| 风寒泻 | 17 | 9(52.9) | 4(23.5) | 4(23.5) | 76.5 |
| 脾虚肾阳虚泻 | 19 | 10(52.6) | 5(26.3) | 4(21.1) | 78.9 |
小儿腹泻乃因外感六淫,乳食不节,脾胃虚弱,其治疗或清热利湿,清肠止泻,或疏风散寒,理气化湿,或健脾益气,升提助运,或补脾温肾,固涩止泻,或清食导滞,和中止泻。治疗组辨证敷脐疗效优于对照组丁桂儿脐贴敷脐(P均<0.05)。治疗组中湿热泻及风寒泻总有效率,痊愈率均明显高于对照组(P均<0.01)。说明辨证敷脐治疗小儿腹泻能迅速缓解病情,提高疗效。
具体实施例:
实施例1:封某,女,1岁5个月。腹泻9个月,每日10余次,均为稀水样,患儿精神怠倦,皮肤干燥,面色萎黄,眼眶下陷,哭时无泪,经多方治疗未见效,后来我科求治。诊断为脾虚肾阳虚泻遂即对症给予本发明中药方加减煎服,方用:焦三仙各10g,鸡内金15g,五味子10g,丁香10g,白头翁15g,山药10g,炒芡实10g,石榴皮10g,云木香10g,肉豆蔻15g,白术10g,茯苓15g,葛根10g,薤白10g,大腹皮10g,黄连10g,陈皮15g,每次20mL,1d 3次;将药渣煎汁灌肠,1d 1次。1周后,解稀软大便,1d 2次,伴随症状明显好转;后经3d巩固治疗,患儿每日解1次成形大便,伴随症状消失。3个月后随访,患儿饮食量增加且精神较好,体重增加4kg,皮肤弹性良好,面色红润,有光泽。
具体实施例2、王某,男,9个月。因腹泻3天于我院接受治疗。查体:T 37.3℃精神可,心肺查体无明显异常,腹部平坦,腹软,未触及包块,无移动性浊音,肠鸣音活跃。大便常规检查示:水样便,伴有发热,哭闹,有脂肪颗粒,无红细胞。诊断:风寒型小儿腹泻。应用本发明方法治疗,方用藿香10g,马齿苋10g,连翘10g,防风15g,白头翁15g,山药10g,炒芡实10g,石榴皮10g,云木香10g,肉豆蔻10g,白术10g,茯苓15g,葛根15g,薤白10g,大腹皮10g,黄连10g,陈皮15g。服用共5天,症状明显好转;后经8d巩固治疗,患儿每日解1次成形大便,伴随症状消失。3个月后随访,患儿饮食量增加且精神较好病人痊愈。
具体实施例3、方某,男,11个月。因腹泻2天于我院接受治疗。查体:T 37.3℃精神可,心肺查体无明显异常,腹部平坦,腹软,未触及包块,无移动性浊音,肠鸣音活跃。大便常规检查示:稀糊状大便,有脂肪颗粒,无红细胞。诊断:湿热型小儿腹泻。应用本发明方法治疗,方用取滑石15g,苍术10g,厚朴15g,薏仁10g,白头翁10g,山药10g,炒芡实10g,石榴皮10g,云木香10g,肉豆蔻10g,白术10g,茯苓15g,葛根10g,薤白10g,大腹皮10g,黄连10g,陈皮10g。共5天,病人痊愈。每次20mL,1d 3次;将药渣煎汁灌肠,1d 1次。1周后,解稀软大便,1d 2次,伴随症状明显好转;后经3d巩固治疗,患儿每日解1次成形大便,伴随症状消失。3个月后随访,患儿饮食量增加且精神较好。
具体实施例4:马某,男8个月,患儿腹泻两月,日行10-20次,呈绿色蛋花样水便;小便排气用力时均能排出大便。患儿精神怠倦,皮肤干燥,面色萎黄,眼眶下陷,哭时无泪,诸药不进,用外敷贴剂,药用:小茴香10g,肉桂10g,葱白10g,生麦芽10g,大青叶10g,黄柏10g,蒲公英10g,细辛10g,每次20mL,1d 3次;将药渣煎汁灌肠,另外再制10副贴剂,每日贴肚脐。停止其他治疗,贴敷此药1周后,解稀软大便,1d 2次,伴随症状明显好转;后经5d巩固治疗,患儿每日解1次成形大便,伴随症状消失。3个月后随访,患儿饮食量增加且精神较好。
Claims (7)
1.一种治疗小儿腹泻的中药组合物,其特征在于,所述中药组合物为内服药物,所述内服药物中,包括以下重量份数比的原料药:白头翁10~15份,山药10~15份,炒芡实10~15份,石榴皮10~15份,云木香10~15份,肉豆蔻10~15份,白术10~15份,茯苓10~15份,葛根10~15份,薤白10~15份,大腹皮10~15份,黄连10~15份,陈皮10~15份。
2.根据权利要求1所述治疗小儿腹泻的中药组合物,其特征在于,所述内服药物进一步包括以下重量份数比的原料药:滑石10~15份,苍术10~15份,厚朴10~15份,薏仁10~15份。
3.根据权利要求1所述治疗小儿腹泻的中药组合物,其特征在于,所述内服药物进一步包括以下重量份数比的原料药:藿香10~15份,马齿苋10~15份,连翘10~15份,防风10~15份。
4.根据权利要求1所述治疗小儿腹泻的中药组合物,其特征在于,所述内服药物进一步包括以下重量份数比的原料药:焦三仙各10份,鸡内金10~15份,五味子10~15份,丁香10~15份。
5.一种如权利要求1~4中任一项所述治疗小儿腹泻的中药组合物的制备方法,其特征在于,所述内服药物的剂型为胶囊剂,其制备方法包括:
a.取原料药加入水提取2次,成浸膏状,为组分1;
b.药渣加乙醇浓缩过滤为浸膏状,为组分2;
c.将上述两种浸膏浓缩干燥成干膏,混合粉碎,加糊精混匀,灌装胶囊。
6.根据权利要求5所述制备方法,其特征在于,所述步骤a中,取原料药加入5-10倍量的水浸泡1-2小时,提取2次;加热提取1-2小时,浓缩至浸膏状,成为组分1。
7.根据权利要求5或6所述制备方法,其特征在于,所述步骤b中,药渣加60-90%乙醇浸泡0.5-1.5小时,提取两次,每次1-2小时,合并提取液,滤过,浓缩,80-160目滤过,6000-10000转/分钟离心后的上清液,经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.35的浸膏,加热回流提取2次,每次30分钟~45分钟,将2次提取液合并静置成浸膏状,作为组分2。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105952883A CN102048933B (zh) | 2010-12-20 | 2010-12-20 | 一种治疗小儿腹泻的中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105952883A CN102048933B (zh) | 2010-12-20 | 2010-12-20 | 一种治疗小儿腹泻的中药组合物及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102048933A CN102048933A (zh) | 2011-05-11 |
| CN102048933B true CN102048933B (zh) | 2012-05-30 |
Family
ID=43953950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105952883A Expired - Fee Related CN102048933B (zh) | 2010-12-20 | 2010-12-20 | 一种治疗小儿腹泻的中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102048933B (zh) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102198262B (zh) * | 2011-05-27 | 2012-07-11 | 孔建 | 一种治疗小儿轮状病毒性肠炎的中药制剂及其制备方法 |
| CN102198261B (zh) * | 2011-05-27 | 2012-08-22 | 孔建 | 一种治疗老年慢性结肠炎的中药制剂及其制备方法 |
| CN102247560B (zh) * | 2011-08-18 | 2013-05-01 | 秦启杰 | 防治兔流行性腹胀病的中草药 |
| CN102836220B (zh) * | 2011-09-05 | 2014-09-03 | 胶南市妇幼保健院 | 治疗小儿慢性腹泻的敷脐中药 |
| CN102641445B (zh) * | 2012-04-08 | 2013-11-13 | 张红 | 一种治疗痢疾的药物及其制备方法 |
| CN102652826B (zh) * | 2012-04-26 | 2014-01-01 | 刘湘 | 一种治疗小儿腹泻的中药颗粒及其制备方法 |
| CN102688438B (zh) * | 2012-05-31 | 2014-01-08 | 柳玉勇 | 一种治疗小儿腹泻的中药口腔崩解片 |
| CN102847124B (zh) * | 2012-09-26 | 2013-12-04 | 张永红 | 一种治疗小儿腹泻的药物及其制备方法 |
| CN102988690B (zh) * | 2012-12-31 | 2014-08-06 | 石家庄市中医院 | 一种治疗小儿秋季腹泻的洗脚用中药 |
| CN103638343B (zh) * | 2013-11-18 | 2016-02-17 | 武汉凌科达科技有限公司 | 防治慢性腹泻的药物的制备方法 |
| CN103610785B (zh) * | 2013-11-20 | 2015-04-01 | 任玉美 | 一种治疗小儿腹泻的中药组合物 |
| CN103690665A (zh) * | 2013-12-12 | 2014-04-02 | 张宗升 | 天然药物组合物 |
| CN103784924B (zh) * | 2014-02-12 | 2016-03-30 | 王贺 | 一种止泻的中药组合物及其制备方法 |
| CN104922377A (zh) * | 2014-02-12 | 2015-09-23 | 胡枫 | 治疗上吐下泻中药制剂的制法 |
| CN103893686A (zh) * | 2014-02-26 | 2014-07-02 | 高雄英 | 一种儿童贴膏及其制备方法 |
| CN104001163B (zh) * | 2014-06-19 | 2016-08-24 | 周洁 | 一种治疗小儿肠炎的药物组合物及其制备方法 |
| CN104096202B (zh) * | 2014-07-18 | 2017-12-29 | 大连大学 | 一种治疗秋季腹泻的药物及其制备方法 |
| CN104107361A (zh) * | 2014-08-06 | 2014-10-22 | 邓继红 | 一种治疗小儿腹泻的药剂 |
| CN104435707A (zh) * | 2014-11-17 | 2015-03-25 | 青岛恒波仪器有限公司 | 一种针对久泻久痢、便血的石榴皮中药茶及其制备方法 |
| CN104721350A (zh) * | 2015-02-27 | 2015-06-24 | 李晓枫 | 一种治疗泄泻的中药组合物 |
| CN104784289A (zh) * | 2015-04-29 | 2015-07-22 | 防城港港美家建材市场投资股份有限公司 | 一种治疗灵长类动物细菌性腹泻的药物 |
| CN105147867A (zh) * | 2015-07-09 | 2015-12-16 | 苏永红 | 一种小儿腹泻贴 |
| CN105079410A (zh) * | 2015-09-08 | 2015-11-25 | 济南舜昊生物科技有限公司 | 一种治疗婴幼儿湿热型腹泻的药物及其制备方法 |
| CN105561129A (zh) * | 2016-01-04 | 2016-05-11 | 四川双鑫生物科技有限公司 | 一种治疗小儿腹泻的内服药物及制备方法 |
| CN105995991A (zh) * | 2016-05-27 | 2016-10-12 | 莫孝爱 | 一种健脾补肾益寿保健品及其制备方法 |
| CN106540149A (zh) * | 2016-12-07 | 2017-03-29 | 李鹏 | 一种含有锅焦成分的改善小儿腹泻的外用药 |
| CN106822759A (zh) * | 2017-02-16 | 2017-06-13 | 成都富豪斯生物科技有限公司 | 一种用于治疗小儿腹泻的内服药物及其制备方法 |
| CN106729191A (zh) * | 2017-03-13 | 2017-05-31 | 何莲英 | 一种脐疗贴的制备方法及应用 |
| CN106822683A (zh) * | 2017-04-11 | 2017-06-13 | 史逸凡 | 一种益敛止泻汤及其制备方法 |
| CN109223886A (zh) * | 2018-11-22 | 2019-01-18 | 贵州优可安生物科技有限公司 | 用于健脾止泻的中药组合物及其制备方法和用途 |
| CN111529658B (zh) * | 2020-06-29 | 2021-08-27 | 山东中医药大学附属医院 | 一种治疗轮状病毒性肠炎的膏剂及制备方法 |
-
2010
- 2010-12-20 CN CN2010105952883A patent/CN102048933B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102048933A (zh) | 2011-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102048933B (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
| CN102068707B (zh) | 一种b超使用的中药助影剂及其制备方法 | |
| CN101797326B (zh) | 一种治疗肠鸣腹泻的中药制剂及其制备方法 | |
| CN102198262B (zh) | 一种治疗小儿轮状病毒性肠炎的中药制剂及其制备方法 | |
| CN101972338B (zh) | 一种治疗小儿上呼吸道感染的中药制剂及其制备方法 | |
| CN103099959B (zh) | 一种治疗溃疡性结肠炎的中药制剂及其制备方法 | |
| CN102205107A (zh) | 一种治疗十二指肠溃疡的中药制剂及其制备方法 | |
| CN102205108B (zh) | 一种治疗胃溃疡的中药制剂及其制备方法 | |
| CN102772781A (zh) | 一种治疗慢性结肠炎的中药制剂及其制备方法 | |
| CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
| CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
| CN105213738A (zh) | 一种用于治疗小儿便秘的中药及其制备方法 | |
| CN106994141B (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
| CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
| CN104274754A (zh) | 一种治疗小儿遗尿的中药组合物及其制备方法 | |
| CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
| CN103520643B (zh) | 一种用于治疗糖尿病白内障的中药制剂及其制备方法 | |
| CN105435190A (zh) | 用于治疗寒热错杂型哮病的中药组合物及其制备方法 | |
| CN105831751A (zh) | 补气健脑的中药保健组合物、制备方法及其使用方法 | |
| CN103041258B (zh) | 治疗小儿呼吸道感染伴纳差不食的中药制剂 | |
| CN103690771B (zh) | 用于治疗羔羊大肠杆菌病的药物及其制备方法 | |
| CN101810751B (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 | |
| CN105920574A (zh) | 一种治疗心悸病的药物及其制备方法 | |
| CN103041259B (zh) | 治疗小儿痰多咳嗽呼吸道感染的中药制剂 | |
| CN105412643A (zh) | 一种治疗小儿水气凌心型哮喘的喷雾剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20121220 |
